This month the PNA Spotlight focuses on endocrinologist Dr. Eliza Geer, the Medical Director of the Multidisciplinary Pituitary and Skull Base Tumor Center and an Associate Attending in the Endocrine Service at Memorial Sloan Kettering Cancer Center in New York City. Dr. Geer got her medical degree from the Icahn School of Medicine at Mount Sinai Medical Center. She completed her internship and residency at the New York-Presbyterian Hospital/Columbia Medical Center. She then did a fellowship in endocrinology and metabolism at the Icahn School of Medicine/Mount Sinai Medical Center, and served on the faculty there for ten years before joining Memorial Sloan Kettering. She was kind enough to answer some questions from the PNA. Her answers can be found below.
This month the PNA Medical Corner focuses on an article co-authored by six members of the PNA, including Drs. Barkhoudarian, Gardner, Prevedello, Kelly, White, and Little. The study looks at the way visual field outcomes are reported in neurosurgical case series and finds significant variations. It concluded that standardized VF data collection guidelines may improve reliability.
~ SONICS Study Met Primary Endpoint with RECORLEV Demonstrating a Statistically Significant Normalization Rate of Urinary Free Cortisol at Six Months ~
~ Key Secondary Endpoints Evaluating Cardiovascular Risk Markers Showed Statistically Significant and Clinically Meaningful Improvements from Baseline ~
~ RECORLEV was Generally Well Tolerated with Only 3.2 Percent of Patients Demonstrating an Increase in Alanine Aminotransferase Measurement of Greater Than Five Times the Upper Limit of Normal~
~ Strongbridge Plans to Discuss Potential for Accelerated Approval of RECORLEV with FDA ~
DUBLIN, Ireland and TREVOSE, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced top-line results from the multinational, pivotal Phase 3 SONICS study evaluating RECORLEV™ (levoketoconazole) for the treatment of endogenous Cushing’s syndrome.
Knowledge is power and we believe keeping abreast of news on the research front is imperative. Each month in Highlights we feature a few of the top news stories, which you can read below. In addition, we update our website on a regular basis with the latest breaking news related to pituitary and hormonal disorders by gathering stories we think you'll be interested in from MD Linx, Medscape, MedPage Today, PubMed, Touch Endocrinology, News-Medical.net and WebMD.
The NYU School of Medicine just announced that it is offering full-tuition scholarships to all current and future students in its MD degree program regardless of need or merit—a bold effort to simultaneously address the rising costs of medical education and still attract the best and brightest students to careers in medicine.
Mt. Sinai Health System in New York reports that it has created an A-I system that can read a CT scan in 1.2 seconds to determine if there are anomalies that could signal a neurological disease. Read more here:
Support the PNA while you shop! Amazon Smile and Goodshop make donations to non profit organizations based on purchases. Click on the images below for information on how you can select the PNA as your charity and earn money for the PNA on all your online purchases.
Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.
Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]
You are receiving this Newsletter because you have shown interest in receiving information about our activities.
If you do not want to receive any more emails from PNA, Unsubscribe.
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.